Preclinical Research and specialist toxicology services and portfolio of drug-development products
Estimated value
—
Awarded value
—
Suppliers
1
Lots
1
1 awarded
Published
12 May 2025
Description
To provide a comprehensive, integrated portfolio of drug-development products and services, preclinical research and toxicology studies to support ongoing research for anticancer compound CADD522.
Scope
- Reference
- Form ID 504
- Commercial tool
- Standalone contract
Submission & procedure
- Procedure
- Below threshold - unknown
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Awarded to